Ono Pharmaceutical Co., Ltd.

OPHLF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income$59$128$144$105
Dep. & Amort.$27$18$17$18
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$38-$29$1-$30
Other Non-Cash-$42-$6-$3-$31
Operating Cash Flow$82$111$160$62
Investing Activities
PP&E Inv.-$5-$4-$14-$12
Net Acquisitions-$365$0-$9-$7
Inv. Purchases-$4-$37-$141-$59
Inv. Sales/Matur.$241$106$56$79
Other Inv. Act.-$3-$17$8$5
Investing Cash Flow-$137$48-$100$6
Financing Activities
Debt Repay.$135$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$0-$50-$0-$30
Dividends Paid-$38-$37-$30-$28
Other Fin. Act.-$3-$3-$3-$3
Financing Cash Flow$94-$90-$32-$60
Forex Effect-$2$1$0$0
Net Chg. in Cash$38$70$27$8
Supplemental Information
Beg. Cash$166$96$69$61
End Cash$205$166$96$69
Free Cash Flow$74$90$145$50